The Daffodil Centre, A Joint Venture Between Cancer Council NSW and The University of Sydney, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
PLoS One. 2023 Apr 5;18(4):e0283939. doi: 10.1371/journal.pone.0283939. eCollection 2023.
Lung cancer is the number one cause of cancer death worldwide. Although international trials demonstrate that targeted screening using low dose computed tomography (LDCT) significantly reduces lung cancer mortality, implementation of screening in the high-risk population presents complex health system challenges that need to be thoroughly understood to support policy change.
To elicit health care providers' and policymakers' views about the acceptability and feasibility of lung cancer screening (LCS) and barriers and enablers to implementation in the Australian setting.
We conducted 24 focus groups and three interviews (22 focus groups and all interviews online) in 2021 with 84 health professionals, researchers, and current cancer screening program managers and policy makers across all Australian states and territories. Focus groups included a structured presentation about lung cancer and screening and lasted approximately one hour each. A qualitative approach to analysis was used to map topics to the Consolidated Framework for Implementation Research.
Nearly all participants considered LCS to be acceptable and feasible but identified a wide range of implementation challenges. Topics (five specific to health systems and five cross-cutting with participant factors) identified were mapped to CFIR constructs, of which 'readiness for implementation', 'planning' and 'executing' were most salient. Health system factor topics included delivery of the LCS program, cost, workforce considerations, quality assurance and complexity of health systems. Participants strongly advocated for streamlined referral processes. Practical strategies to address equity and access, such as using mobile screening vans, were emphasised.
Key stakeholders readily identified the complex challenges associated with the acceptability and feasibility of LCS in Australia. The barriers and facilitators across health system and cross-cutting topics were clearly elicited. These findings are highly relevant to the scoping of a national LCS program by the Australian Government and a subsequent recommendation for implementation.
肺癌是全球癌症死亡的首要原因。尽管国际试验表明,使用低剂量计算机断层扫描(LDCT)进行靶向筛查可显著降低肺癌死亡率,但在高危人群中实施筛查带来了复杂的卫生系统挑战,需要深入了解这些挑战,以支持政策的改变。
了解澳大利亚卫生保健提供者和决策者对肺癌筛查(LCS)的可接受性和可行性的看法,以及在澳大利亚实施筛查的障碍和促进因素。
我们于 2021 年在澳大利亚所有州和地区进行了 24 次焦点小组和 3 次访谈(22 次焦点小组和所有访谈均在线),共 84 名卫生专业人员、研究人员、当前癌症筛查项目管理者和政策制定者参加。焦点小组包括一个关于肺癌和筛查的结构化介绍,每次持续约一个小时。采用定性方法对分析结果进行了分析,将主题映射到实施研究的综合框架中。
几乎所有参与者都认为 LCS 是可以接受和可行的,但也确定了广泛的实施挑战。确定的主题(五个与卫生系统相关,五个与参与者因素交叉)被映射到 CFIR 结构,其中“实施准备”、“规划”和“执行”最为突出。卫生系统因素主题包括 LCS 计划的实施、成本、劳动力考虑、质量保证和卫生系统的复杂性。参与者强烈主张简化转诊流程。强调了一些实用的策略,如使用移动筛查车,以解决公平和可及性问题。
主要利益相关者清楚地认识到澳大利亚 LCS 可接受性和可行性所涉及的复杂挑战。明确地确定了卫生系统和交叉主题的障碍和促进因素。这些发现与澳大利亚政府对全国性 LCS 计划的范围界定以及随后的实施建议高度相关。